681 related articles for article (PubMed ID: 25559883)
1. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.
Skillbäck T; Rosén C; Asztely F; Mattsson N; Blennow K; Zetterberg H
JAMA Neurol; 2014 Apr; 71(4):476-83. PubMed ID: 24566866
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
[TBL] [Abstract][Full Text] [Related]
5. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
[TBL] [Abstract][Full Text] [Related]
6. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
[TBL] [Abstract][Full Text] [Related]
7. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
[TBL] [Abstract][Full Text] [Related]
8. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
[TBL] [Abstract][Full Text] [Related]
9. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.
Holsinger RM; Lee JS; Boyd A; Masters CL; Collins SJ
Neurology; 2006 Aug; 67(4):710-2. PubMed ID: 16924032
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
11. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
Van Everbroeck B; Boons J; Cras P
Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
Blennow K; Johansson A; Zetterberg H
Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
[TBL] [Abstract][Full Text] [Related]
14. Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Cepek L; Steinacker P; Mollenhauer B; Wiese B; Ciesielczyk B; Bibl M; Wiltfang J; Zerr I; Schulz-Schaeffer W; Kretzschmar HA; Poser S; Otto M
Dement Geriatr Cogn Disord; 2005; 19(5-6):376-82. PubMed ID: 15802913
[TBL] [Abstract][Full Text] [Related]
15. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease?
Humpel C; Benke T
Pharmacology; 2017; 100(5-6):243-245. PubMed ID: 28743115
[TBL] [Abstract][Full Text] [Related]
17. Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease.
Torres M; Cartier L; Matamala JM; Hernández N; Woehlbier U; Hetz C
PLoS One; 2012; 7(4):e36159. PubMed ID: 22558368
[TBL] [Abstract][Full Text] [Related]
18. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
[TBL] [Abstract][Full Text] [Related]
20. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
Blennow K; Diaz-Lucena D; Zetterberg H; Villar-Pique A; Karch A; Vidal E; Hermann P; Schmitz M; Ferrer Abizanda I; Zerr I; Llorens F
J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):846-853. PubMed ID: 31097472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]